The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems

Immunologic Research

Volumn 61, Issue 1-2, 2015, Pages 90-96

  Pellegrino, Paolo ^a   Perrone, Valentina ^a   Pozzi, Marco ^b   Carnovale, Carla ^a   Perrotta, Cristiana ^a   Clementi, Emilio ^a,b   Radice, Sonia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Adjuvants; ASIA; HPV; Post vaccination; Vaccine

Indexed keywords

WART VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT;

ADOLESCENT; ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE INFLAMMATORY SYNDROME; AUTOINFLAMMATORY DISEASE; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; EVALUATION STUDY; FEMALE; FEVER; HLA SYSTEM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; VACCINATION; VACCINATION REACTION; AUTOIMMUNE DISEASES; CHILD; FACTUAL DATABASE; INFLAMMATION; SYNDROME; UNITED STATES; YOUNG ADULT;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CHILD; DATABASES, FACTUAL; FEMALE; HUMANS; INFLAMMATION; MALE; PAPILLOMAVIRUS VACCINES; SYNDROME; UNITED STATES; YOUNG ADULT;

EID: 84925497065     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-014-8567-3     Document Type: Article

References (41)

1. Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8. doi:10.1016/j.jaut.2010.07.003.
2. Meroni PL. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome? J Autoimmun. 2011;36(1):1–3. doi:10.1016/j.jaut.2010.10.004.
3. Carvalho JF, Barros SM. ASIA or Shoenfeld’s syndrome: a novel autoimmune syndrome? Rev Bras Reumatol. 2010;50(5):487–8.
4. Carvalho JF, Barros SM, Branco JC, Fonseca JE. Asia or Shoenfeld’s syndrome: highlighting different perspectives for diffuse chronic pain. Acta Reumatol Port. 2011;36(1):10–2.
5. Agmon-Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus. 2012;21(2):118–20. doi:10.1177/0961203311429316.
6. Perricone C, Shoenfeld Y. Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). J Clin Rheumatol. 2013;19(5):231–3. doi:10.1097/RHU.0b013e31829d56f1.
7. Toubi E. ASIA-autoimmune syndromes induced by adjuvants: rare, but worth considering. Isr Med Assoc J. 2012;14(2):121–4.
8. Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases. Lupus. 2012;21(2):146–52. doi:10.1177/0961203311429318.
9. Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, et al. No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol. 2013;28(8):705–7. doi:10.1007/s10654-013-9830-y.
10. Pellegrino P, Carnovale C, Pozzi M, Antoniazzi S, Perrone V, Salvati D, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev. 2014;13(7):736–41. doi:10.1016/j.autrev.2014.01.054.
11. Perricone C, Agmon-Levin N, Valesini G, Shoenfeld Y. Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. Joint Bone Spine. 2012;79(1):1–3. doi:10.1016/j.jbspin.2011.10.006.
12. Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, et al. Can HPV immunisation cause ADEM? Two case reports and literature review. Mult Scler. 2014;20(6):762–3. doi:10.1177/1352458513502114.
13. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Antoniazzi S, et al. Human papillomavirus vaccine in patients with systemic lupus erythematosus. Epidemiology. 2014;25(1):155–6. doi:10.1097/EDE.0000000000000033.
14. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the association between human papillomavirus vaccine and primary ovarian failure. Am J Reprod Immunol. 2014;71(4):293–4. doi:10.1111/aji.12190.
15. Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, et al. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012;30(50):7253–9. doi:10.1016/j.vaccine.2012.09.074.
16. Harper DM, Irons BB, Alexander NM, Comes JC, Smith MS, Heutinck MA, et al. Quantifying the decisional satisfaction to accept or reject the Human Papillomavirus (HPV) vaccine: a preference for cervical cancer prevention. PLoS One. 2014;9(2):e88493. doi:10.1371/journal.pone.0088493.
17. Szarewski A, Skinner SR, Garland SM, Romanowski B, Schwarz TF, Apter D, et al. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation. J Infect Dis. 2013;208(9):1391–6. doi:10.1093/infdis/jit360.
18. Harper DM, Vierthaler SL. Next generation cancer protection: the bivalent HPV vaccine for females. ISRN Obstet Gynecol. 2011;2011:457204. doi:10.5402/2011/457204.
19. Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):100–10. doi:10.1016/S1470-2045(11)70287-X.
20. Pellegrino P, Carnovale C, Cattaneo D, Perrone V, Antoniazzi S, Pozzi M, et al. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy. Health Policy. 2013;113(1–2):216–20. doi:10.1016/j.healthpol.2013.08.006.
21. Blank M, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus. 2012;21(7):711–4. doi:10.1177/0961203312438115.
22. Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA): animal models as a proof of concept. Curr Med Chem. 2013;20(32):4030–6.
23. Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1–16. doi:10.1016/j.jaut.2013.10.004.
24. Soriano A, Butnaru D, Shoenfeld Y. Long-term inflammatory conditions following silicone exposure: the expanding spectrum of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Clin Exp Rheumatol. 2014;32(2):151–4.
25. Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Clementi E, et al. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PLoS One. 2013;8(10):e77766. doi:10.1371/journal.pone.0077766.
26. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol. 2014;70(3):369–71. doi:10.1007/s00228-013-1616-3.
27. Pellegrino P, Clementi E, Radice S. Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol. 2014;. doi:10.1007/s00228-014-1689-7.
28. Pellegrino P, Carnovale C, Radice S, Clementi E. Influenza-like illness after yellow fever vaccination. J Clin Virol. 2014;. doi:10.1016/j.jcv.2014.03.015.
29. Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, et al. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine. 2014;32(15):1661–9. doi:10.1016/j.vaccine.2014.01.057.
30. Ovsyannikova IG, Jacobson RM, Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics. 2004;5(4):417–27. doi:10.1517/14622416.5.4.417.
31. Pellegrino P, Falvella FS, Perrone V, Carnovale C, Brusadelli T, Pozzi M, et al. The first steps towards the era of personalised vaccinology: predicting adverse reactions. Pharmacogenomics J. 2014;. doi:10.1038/tpj.2014.57.
32. Pellegrino P, Clementi E, Capuano A, Radice S. Can vaccines interact with drug metabolism? Pharmacol Res. 2014. doi:10.1016/j.phrs.2014.09.003.
33. Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S, et al. Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine. 2014;32(37):4730–5. doi:10.1016/j.vaccine.2014.06.068.
34. Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V, et al. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol. 2013;69(8):1615–6. doi:10.1007/s00228-013-1517-5.
35. Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines. 2014;13(5):657–69. doi:10.1586/14760584.2014.905744.
36. Klein SL, Poland GA. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine. 2013;31(23):2599–600. doi:10.1016/j.vaccine.2013.02.070.
37. Mitchell LA, Tingle AJ, MacWilliam L, Horne C, Keown P, Gaur LK, et al. HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis. 1998;177(1):5–12.
38. Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States. Eur J Clin Microbiol Infect Dis. 2014;33(9):1519–24. doi:10.1007/s10096-014-2102-2.
39. Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215–24. doi:10.1016/j.autrev.2013.10.003.
40. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5(11):648–52. doi:10.1038/nrrheum.2009.196.
41. Agmon-Levin N, Arango MT, Kivity S, Katzav A, Gilburd B, Blank M et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014. doi:10.1016/j.jaut.2014.06.006.